tiprankstipranks
Biovaxys Technology Corp (BVAXF)
:BVAXF
US Market
Holding BVAXF?
Track your performance easily

BioVaxys Technology (BVAXF) Financial Statements

31 Followers

BioVaxys Technology Financial Overview

BioVaxys Technology's market cap is currently ―. The company's EPS TTM is $-0.021; its P/E ratio is ―; BioVaxys Technology is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jul 24Apr 24Jan 24Oct 23Jul 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.19M$ -542.39K$ 518.05K$ -3.67M$ -2.92M
EBITDA$ -1.19M$ -542.39K$ 518.05K$ -3.67M$ -2.92M
Net Income Common Stockholders$ -1.19M$ -542.39K$ 518.05K$ -3.67M$ -2.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 490.85K$ 159.74K$ 965.13K$ 977.00$ 423.00
Total Assets$ 2.41M$ 1.77M$ 1.48M$ 113.48K$ 1.41M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 2.66M$ 2.79M$ 2.87M$ 3.49M$ 2.04M
Stockholders Equity$ -249.19K$ -1.03M$ -1.40M$ -3.37M$ -624.21K
Cash Flow-
Free Cash Flow$ -412.20K$ -1.49M$ 2.38K$ -2.02K$ -23.74K
Operating Cash Flow$ -412.20K$ -436.93K$ 2.38K$ -2.02K$ -23.74K
Investing Cash Flow$ -1.00$ -1.06M---
Financing Cash Flow$ 743.40K$ 687.94K$ 962.67K--
Currency in USD

BioVaxys Technology Earnings and Revenue History

BioVaxys Technology Debt to Assets

BioVaxys Technology Cash Flow

BioVaxys Technology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis